Filing Details
- Accession Number:
- 0001209191-16-145577
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-10-11 16:33:00
- Reporting Period:
- 2016-10-07
- Filing Date:
- 2016-10-11
- Accepted Time:
- 2016-10-11 16:33:00
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
879169 | Incyte Corp | INCY | Services-Commercial Physical & Biological Research (8731) | 943136539 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1615842 | P Barry Flannelly | 1801 Augustine Cut-Off Wilmington DE 19803 | Evp & General Manager Us | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2016-10-07 | 2,408 | $48.44 | 13,595 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2016-10-07 | 21,796 | $48.44 | 35,391 | No | 4 | M | Direct | |
Common Stock | Disposition | 2016-10-07 | 24,204 | $97.00 | 11,187 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Incentive Stock Option (right to buy) | Disposition | 2016-10-07 | 2,408 | $0.00 | 2,408 | $48.44 |
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2016-10-07 | 21,796 | $0.00 | 21,796 | $48.44 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
3,784 | 2021-08-10 | No | 4 | M | Direct | |
20,422 | 2021-08-10 | No | 4 | M | Direct |
Footnotes
- This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person.
- Includes an aggregate of 11,187 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
- Beginning August 11, 2014, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years